Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis

PHASE2CompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

May 4, 2018

Study Completion Date

May 4, 2018

Conditions
Candida Vulvovaginitis
Interventions
DRUG

Fluconazole

Oral Antifungal comparator

DRUG

SCY-078

Investigational Antifungal

Trial Locations (25)

19102

Drexel University, Philadelphia

27408

Unified Women's Clinical Research - Central Carolina, Greensboro

27612

Wake Research Associates, LLC, Raleigh

29407

Medical Research South, LLC, Charleston

30075

Atlanta North Gynecology, P.C., Roswell

33160

Visionary Investigators Network, South Miami

33186

New Age Medical Research Corp., Miami

33461

Altus Research, Inc., Lake Worth

33510

Gulf Coast Research Group, LLC, Brandon

34748

OB-GYN Associates of Mid-Florida P.A., Leesburg

35294

UAB Personal Health Clinic, Birmingham

38120

WR-Medical Research Center of Memphis, LLC, Memphis

48201

Tolan Park Medical Building, Detroit

63131

Consultants in Women's Healthcare, Inc., St Louis

67226

Cypress Medical Research Center, LLC, Wichita

70006

Clinical Trials Management, LLC, Metairie

70125

Women Under Study, LLC, New Orleans

70433

Clinical Trials Management, LLC, Covington

77054

Tmc Life Research, Inc., Houston

78229

Clinical Trials of Texas, Inc., San Antonio

85032

Precision Trials AZ, LLC, Phoenix

92111

Women's Health Care Research Corp., San Diego

98105

Seattle Women's Health, Research, Gynecology, Seattle

08648

Lawrence OB/GYN Clinical Research, LLC, Lawrenceville

08536

Women's Health Research Center, Plainsboro

All Listed Sponsors
lead

Scynexis, Inc.

INDUSTRY

NCT03253094 - Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis | Biotech Hunter | Biotech Hunter